Intestinal Guanylate Cyclase‐C mRNA Expression in Duodenum and Colon of Children

• Published in: Journal of pediatric gastroenterology and nutrition Vol. 73; no. 6; pp. 703 - 709
• Main Authors: Cohen, Mitchell B., Gold, Benjamin D., Xanthakos, Stavra A., CaJacob, Nicholas, Weissman, Taryn, Bartolini, Wilmin, Boinpally, Ramesh, Mallick, Madhuja, Reasner, David S., O'Dea, Christopher R., Kwak, Hanna, Ge, Pei
• Format: Journal Article
• Language: English
• Published: United States 01.12.2021
• Subjects: Adolescent; Child; Child, Preschool; Colon - metabolism; Duodenum - metabolism; Guanylate Cyclase - metabolism; guanylate cyclase‐C receptors; Humans; Infant; intestinal epithelium; Intestinal Mucosa - metabolism; pediatrics; RNA, Messenger - metabolism; safety
• ISSN: 0277-2116; 1536-4801
• DOI: 10.1097/MPG.0000000000003296

ABSTRACT Objectives: Guanylate cyclase‐C (GC‐C) agonists, which increase intestinal secretion and accelerate transit, are used to treat chronic constipation and constipation‐predominant irritable bowel syndrome and are being evaluated for pediatric use. Prior studies suggest GC‐C receptor density may be higher in young children, potentially amplifying GC‐C agonism with treatment implications. We aimed to quantitate duodenal and colonic GC‐C mRNA expression in children. Methods: Mucosal biopsies were obtained from subjects aged 6 months to 18 years during clinically indicated upper, that is, esophago‐gastro‐duodenal, and/or colonic endoscopy. Tissue samples without histologic abnormalities were grouped by subject age (<24 months, 24 months to <6 years, 6 to <12 years, and 12 to <18 years) and analyzed for GC‐C mRNA expression by qPCR. The relationship between GC‐C mRNA levels and age was modeled using regression analyses. Results: Ninety‐nine subjects underwent upper endoscopy/colonoscopy; 93 had evaluable samples. Mean relative GC‐C mRNA expression was 2.36 (range 2.21–2.46) for duodenal samples and 1.56 (range 1.22–1.91) for colonic samples. Predicted and observed normalized GC‐C mRNA expression in each region were comparable among age groups. Pooled expression by region demonstrated lower expression in colonic versus duodenal samples. Conclusions: Uniform levels of GC‐C mRNA expression were detected in children aged >6 months in the duodenum and >12 months in the colon. Higher expression was observed in all age groups in duodenal versus colonic samples, indicating regional variability in GC‐C receptor density. These data are reassuring for further studies of GC‐C agonists in children.